Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1070230081
JPRN-jRCT1070230081
Not Yet Recruiting
N/A

A prospective, multicenter, epidemiological study to estimate the burden of Respiratory syncytial virus (RSV) infection in Older ADults with acute respiratory infection (ARI) across Nagasaki and environ in Japan: Nagasaki ROAD study

Takazono Takahiro0 sites5,400 target enrollmentNovember 5, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute respiratory infection due to respiratory syncytial virus

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute respiratory infection due to respiratory syncytial virus
Sponsor
Takazono Takahiro
Enrollment
5400
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Takazono Takahiro

Eligibility Criteria

Inclusion Criteria

  • •A male or female aged \>\- 50 years at onset of ARI.
  • •\-Participants diagnosed with at least two ARI symptoms/signs meeting the ARI case definition, for at least 12 hours, and an onset date of first symptom/sign less than 7 days before the medical visit at study sites.
  • •\-Participants who in the opinion of the investigator, can and will comply with the requirements of the study procedures (e.g., agree to provide nasopharyngeal swab samples).
  • •\-Participants who are able to provide written informed consent. If a participant is unable to write the informed consent at the time of Day 1, a family member who takes care of the participant (associated caregiver) can provide written informed consent on their behalf as a legal representative.

Exclusion Criteria

  • •\-Re\-enrolment if new ARI symptoms/signs are reported within 14 days from the previous ARI episode.
  • •\-Participants' ARI symptoms/signs derived from aspiration pneumonia diagnosed by the investigators.
  • •\-Participant is deemed to be ineligible for the study for any other reason by the investigator or sub\-investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Multi-center cross-sectional epidemiological study tounderstand the prevalence and distribution oflipoprotein(a) levels among patients with establishedcardiovascular diseaseHealth Condition 1: I259- Chronic ischemic heart disease, unspecified
CTRI/2019/04/018392ovartis Healthcare Pvt Ltd
Completed
N/A
Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease
NL-OMON48235ovartis3,700
Completed
N/A
An observational multicenter study comparing Tenecteplase assisted Percutaneous Coronary Intervention (PCI) versus primary PCI in Indian patients with ST elevation Myocardial InfarctioHealth Condition 1: null- Patients with acute STEMI who are to be treated with primary PCI/pharmacoinvasive therapy within 12 hours of symptoms onset will be included.
CTRI/2011/08/001950STEMI India Charitable Trust200
Completed
N/A
A multicenter, prospective, observational study evaluation the learning effect of an e-learning system-based teaching method on biliary cannulation for native papilla in ERCP
JPRN-UMIN000044223Iwata city hospital12
Completed
N/A
To study Mucormycosis epidemiology in IndiaHealth Condition 1: null- Patients who diagnosed with MucormycosisHealth Condition 2: B46- Zygomycosis
CTRI/2016/02/006644MYLAN PHARMACEUTICALS PRIVATE LIMITED465